FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2575101868> ?p ?o ?g. }

• W2575101868 endingPage "439" @default.
• W2575101868 startingPage "439" @default.
• W2575101868 abstract "This study explored the relationship between the fractional exhaled nitric oxide (FeNO) level and the efficacy of inhaled corticosteroid (ICS) in asthma-chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) patients with different disease severity. A total of 127 ACOS patients with ACOS (case group) and 131 healthy people (control group) were enrolled in this study. Based on the severity of COPD, the ACOS patients were divided into: mild ACOS; moderate ACOS; severe ACOS; and extremely severe ACOS groups. We compared FeNO levels, pulmonary function parameters including percentage of forced expiratory volume in 1 second (FEV1) to predicted value (FEV1%pred), ratio of FEV1 to forced vital capacity (FEV1/FVC), inspiratory capacity to total lung capacity (IC/TLC) and residual volume to total lung capacity (RV/TLC), arterial blood gas parameters, including PH, arterial partial pressure of oxygen (PaO₂) and arterial partial pressure of carbon dioxide (PaCO₂), total serum immunoglobulin E (IgE), induced sputum eosinophil (EOS), plasma surfactant protein A (SP-A), plasma soluble receptor for advanced glycation end products (sRAGE), sputum myeloperoxidase (MPO), sputum neutrophil gelatinase-associated lipocalin (NGAL) and Asthma Control Test (ACT) scores, and COPD Assessment Test (CAT) scores. Compared with pre-treatment parameters, the FeNO levels, RV/TLC, PaCO₂, total serum IgE, induced sputum EOS, plasma SP-A, sputum MPO, sputum NGAL, and CAT scores were significantly decreased after 6 months of ICS treatment, while FEV1%pred, FEV1/FVC, IC/TLC, PH, PaO2, plasma sRAGE, and ACT scores were significantly increased in ACOS patients with different disease severity after 6 months of ICS treatment. This finding suggests that the FeNO level may accurately predict the efficacy of ICS in the treatment of ACOS patients." @default.
• W2575101868 created "2017-01-26" @default.
• W2575101868 creator A5017850570 @default.
• W2575101868 creator A5020389679 @default.
• W2575101868 creator A5041357741 @default.
• W2575101868 creator A5052901154 @default.
• W2575101868 creator A5070529179 @default.
• W2575101868 creator A5081341048 @default.
• W2575101868 creator A5089258484 @default.
• W2575101868 date "2017-01-01" @default.
• W2575101868 modified "2023-10-13" @default.
• W2575101868 title "Relationship between Fractional Exhaled Nitric Oxide Level and Efficacy of Inhaled Corticosteroid in Asthma-COPD Overlap Syndrome Patients with Different Disease Severity" @default.
• W2575101868 cites W1491379818 @default.
• W2575101868 cites W1631606267 @default.
• W2575101868 cites W1762740332 @default.
• W2575101868 cites W1819273466 @default.
• W2575101868 cites W1824858941 @default.
• W2575101868 cites W1843347731 @default.
• W2575101868 cites W1913610488 @default.
• W2575101868 cites W1967707720 @default.
• W2575101868 cites W1981343823 @default.
• W2575101868 cites W2009949936 @default.
• W2575101868 cites W2024817365 @default.
• W2575101868 cites W2025335465 @default.
• W2575101868 cites W2030480367 @default.
• W2575101868 cites W2035982952 @default.
• W2575101868 cites W2068836059 @default.
• W2575101868 cites W2099775332 @default.
• W2575101868 cites W2112669319 @default.
• W2575101868 cites W2118042990 @default.
• W2575101868 cites W2141343329 @default.
• W2575101868 cites W2142447425 @default.
• W2575101868 cites W2149147476 @default.
• W2575101868 cites W2156400407 @default.
• W2575101868 cites W2157522746 @default.
• W2575101868 cites W2157968241 @default.
• W2575101868 cites W2254656890 @default.
• W2575101868 cites W2288803882 @default.
• W2575101868 cites W2289002669 @default.
• W2575101868 cites W2290182855 @default.
• W2575101868 cites W2292306024 @default.
• W2575101868 cites W2294400146 @default.
• W2575101868 cites W2313972046 @default.
• W2575101868 cites W2326847380 @default.
• W2575101868 cites W2337193334 @default.
• W2575101868 cites W2341948965 @default.
• W2575101868 cites W2418898174 @default.
• W2575101868 cites W2462668116 @default.
• W2575101868 cites W2616424562 @default.
• W2575101868 cites W4211006694 @default.
• W2575101868 doi "https://doi.org/10.3346/jkms.2017.32.3.439" @default.
• W2575101868 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5290103" @default.
• W2575101868 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28145647" @default.
• W2575101868 hasPublicationYear "2017" @default.
• W2575101868 type Work @default.
• W2575101868 sameAs 2575101868 @default.
• W2575101868 citedByCount "23" @default.
• W2575101868 countsByYear W25751018682017 @default.
• W2575101868 countsByYear W25751018682018 @default.
• W2575101868 countsByYear W25751018682020 @default.
• W2575101868 countsByYear W25751018682021 @default.
• W2575101868 countsByYear W25751018682022 @default.
• W2575101868 crossrefType "journal-article" @default.
• W2575101868 hasAuthorship W2575101868A5017850570 @default.
• W2575101868 hasAuthorship W2575101868A5020389679 @default.
• W2575101868 hasAuthorship W2575101868A5041357741 @default.
• W2575101868 hasAuthorship W2575101868A5052901154 @default.
• W2575101868 hasAuthorship W2575101868A5070529179 @default.
• W2575101868 hasAuthorship W2575101868A5081341048 @default.
• W2575101868 hasAuthorship W2575101868A5089258484 @default.
• W2575101868 hasBestOaLocation W25751018681 @default.
• W2575101868 hasConcept C126322002 @default.
• W2575101868 hasConcept C142724271 @default.
• W2575101868 hasConcept C165637977 @default.
• W2575101868 hasConcept C2776042228 @default.
• W2575101868 hasConcept C2776301714 @default.
• W2575101868 hasConcept C2776780178 @default.
• W2575101868 hasConcept C2777714996 @default.
• W2575101868 hasConcept C2780333948 @default.
• W2575101868 hasConcept C2781069245 @default.
• W2575101868 hasConcept C2781142857 @default.
• W2575101868 hasConcept C3018587741 @default.
• W2575101868 hasConcept C55520419 @default.
• W2575101868 hasConcept C71924100 @default.
• W2575101868 hasConcept C90924648 @default.
• W2575101868 hasConceptScore W2575101868C126322002 @default.
• W2575101868 hasConceptScore W2575101868C142724271 @default.
• W2575101868 hasConceptScore W2575101868C165637977 @default.
• W2575101868 hasConceptScore W2575101868C2776042228 @default.
• W2575101868 hasConceptScore W2575101868C2776301714 @default.
• W2575101868 hasConceptScore W2575101868C2776780178 @default.
• W2575101868 hasConceptScore W2575101868C2777714996 @default.
• W2575101868 hasConceptScore W2575101868C2780333948 @default.
• W2575101868 hasConceptScore W2575101868C2781069245 @default.
• W2575101868 hasConceptScore W2575101868C2781142857 @default.
• W2575101868 hasConceptScore W2575101868C3018587741 @default.
• W2575101868 hasConceptScore W2575101868C55520419 @default.
• W2575101868 hasConceptScore W2575101868C71924100 @default.

• next